During 14-16 March 2021, 4th World Congress and Expo on Traditional and Alternative Medicine is organized in collaboration with Taipei Chinese Medical Association, Meridian World Health Organization Alliance (MWHOA), Chang Gung University, Tzu Chi University, I Shou University, and China Medical University. The Congress focused on the theme “World Health for everyone with local Wisdom and Resources,” with the domestic well-known speakers and international scholars were invited to publish the research of traditional and alternative medical therapies for global health issues through this online conference. The Head of Technology of SunWay Biotech, Dr. Tzu-Ming Pan, was invited as a speaker by Taipei Chinese Medical Association and Global Scientific Guild to announce at the conference that heart health supplement plays an important role for global health.

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally. WHO says that about 17.9 million people worldwide died from CVDs in 2016 alone, representing 31 percent of all global deaths. Moreover, amid the COVID-19 crisis, the global market for Heart Healthy Ingredients estimated at US$16.6 Billion in the year 2020, is projected to reach a revised size of US$24.8 Billion by 2027, growing at a of 5.9% over the analysis period 2020-2027.

Red yeast rice, as a dietary supplement ingredient for heart health, is prized for its ability to lower cholesterol and maintain healthy blood glucose and blood pressure levels. But, currently, most red yeast rice supplements are barred from the US and other markets because of their monacolin K content, which is considered in the US to be a drug and not a supplement.

ANKASCIN® 568-R, is an extract of fermented products of Monascus purpureus NTU 568. Its technique including this particular strain was transferred from the laboratory of Professor Tzu-Ming Pan at National Taiwan University. ANKASCIN® 568-R answers the call for a safe and effective red yeast rice supplement ingredient, since it includes the active compounds beneficial for heart health and no monacolin K. Backed by myriad clinical trials, the ingredient is FDA approved as a new dietary ingredient and holds 22 patents worldwide. And, with heart disease on the rise worldwide, the market potential for such an ingredient holds enormous potential.

It is undeniable that consumers are concerned about staying healthy as they age, particularly when it comes to heart and cognitive health, says Dr. Pan. Incidence of hypertension, diabetes, and high cholesterol are on the rise worldwide. And, because these are all risk factors for cardiovascular disease, consumers are looking for a way to manage or mitigate these symptoms with natural dietary supplements either in tandem with or without the use of pharmaceuticals. Therefore, the red yeast rice extract, ANKASCIN® 568-R, holds enormous potential for cardiovascular health worldwide.

Dr. Tzu-Ming Pan was invited as speaker in the 4th World Congress and Expo on Traditional and Alternative Medicine

Dr. Tzu-Ming Pan was interviewed by the Formosa TV